Publication: Randomized trial of isosorbide mononitrate versus misoprostol for cervical ripening at term
1
Issued Date
2002-01-01
Resource Type
ISSN
00207292
Other identifier(s)
2-s2.0-0036024095
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
International Journal of Gynecology and Obstetrics. Vol.78, No.2 (2002), 139-145
Suggested Citation
B. Chanrachakul, Y. Herabutya, P. Punyavachira Randomized trial of isosorbide mononitrate versus misoprostol for cervical ripening at term. International Journal of Gynecology and Obstetrics. Vol.78, No.2 (2002), 139-145. doi:10.1016/S0020-7292(02)00128-5 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/20581
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Randomized trial of isosorbide mononitrate versus misoprostol for cervical ripening at term
Author(s)
Other Contributor(s)
Abstract
Objectives: To assess the adverse effects of isosorbide mononitrate (IMN) compared with misoprostol for cervical ripening at term. Methods: One hundred and seven women with term pregnancies referred for induction of labor with Bishop scores of 6 or less were randomly allocated to receive either a 40-mg IMN tablet vaginally (n=55) or 50 μg misoprostol vaginally (n=52) every 6 h for a maximum of three doses. They were sent to the labor ward for amniotomy or oxytocin if either their Bishop scores were more than 6 or their cervices were not ripe 24 h after the treatment. Adverse effects, progress, and outcomes of labor were assessed. Results: Isosorbide mononitrate was associated with fewer adverse effects especially uterine tachysystole (0 vs. 19.2%, P<0.01) and hyperstimulation (0 vs. 15.4%, P<0.01). The time from start of medication to vaginal delivery in IMN group was significantly longer (25.6±6.1 vs. 14±6.9 h, P<0.01). Oxytocin was needed in 51 women (92%) of the isosorbide mononitrate group and six women (11%) of the misoprostol group (P<0.001). The cesarean rate was not significantly different between the groups, but the major indications were different: dystocia (45%) in the IMN group vs. persistent non-reassuring fetal heart rate pattern (56%) in the misoprostol group. Conclusions: Cervical ripening with IMN resulted in fewer adverse effects, but was less effective than misoprostol. © 2002 International Federation of Gynecology and Obstetrics. Published by Elsevier Science Ireland Ltd. All rights reserved.